Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cass

Showing results (211-220 of 304) with videos related to

Pageof 31
Sort By:
Journal of the National Cancer Institute|November 5, 1999
Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transportersJ R Mackey, S Y Yao, K M Smith, et al.
Leukemia|August 30, 2002
Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case studyT Reiman, K A Graham, J Wong, et al.
The Biochemical Journal|May 9, 2008
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivityRobert J Paproski, Frank Visser, Jing Zhang, et al.
Neuropharmacology|April 20, 2001
Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous systemL L Jennings, C Hao, M A Cabrita, et al.
The Journal of Biological Chemistry|November 14, 1997
Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissuesS Y Yao, A M Ng, W R Muzyka, et al.
Journal of Neurochemistry|July 31, 1999
Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brainC M Anderson, W Xiong, J D Geiger, et al.
The Biochemical Journal|March 23, 1999
Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q)M F Vickers, R S Mani, M Sundaram, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 19, 2002
Immunocytochemical demonstration of the equilibrative nucleoside transporter rENT1 in rat sinoatrial nodeH Musa, H Dobrzynski, Z Berry, et al.
Journal of Medicinal Chemistry|August 20, 2010
Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabineMorris J Robins, Yunshan Peng, Vijaya L Damaraju, et al.
Plos One|February 27, 2013
Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptakeRobert J Paproski, Sylvia Y M Yao, Nicole Favis, et al.
Pageof 31

Showing results (211-220 of 304) with videos related to

Sort By:
Pageof 31
Journal of the National Cancer Institute|November 5, 1999
Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transportersJ R Mackey, S Y Yao, K M Smith, et al.
Leukemia|August 30, 2002
Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: a molecular case studyT Reiman, K A Graham, J Wong, et al.
The Biochemical Journal|May 9, 2008
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivityRobert J Paproski, Frank Visser, Jing Zhang, et al.
Neuropharmacology|April 20, 2001
Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous systemL L Jennings, C Hao, M A Cabrita, et al.
The Journal of Biological Chemistry|November 14, 1997
Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissuesS Y Yao, A M Ng, W R Muzyka, et al.
Journal of Neurochemistry|July 31, 1999
Distribution of equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporters (ENT1) in brainC M Anderson, W Xiong, J D Geiger, et al.
The Biochemical Journal|March 23, 1999
Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q)M F Vickers, R S Mani, M Sundaram, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 19, 2002
Immunocytochemical demonstration of the equilibrative nucleoside transporter rENT1 in rat sinoatrial nodeH Musa, H Dobrzynski, Z Berry, et al.
Journal of Medicinal Chemistry|August 20, 2010
Improved syntheses of 5'-S-(2-aminoethyl)-6-N-(4-nitrobenzyl)-5'-thioadenosine (SAENTA), analogues, and fluorescent probe conjugates: analysis of cell-surface human equilibrative nucleoside transporter 1 (hENT1) levels for prediction of the antitumor efficacy of gemcitabineMorris J Robins, Yunshan Peng, Vijaya L Damaraju, et al.
Plos One|February 27, 2013
Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptakeRobert J Paproski, Sylvia Y M Yao, Nicole Favis, et al.
Pageof 31